Forte Biosciences Stock Price on September 18, 2024
| FBRX Stock | USD 19.79 3.11 18.65% |
Below is the normalized historical share price chart for Forte Biosciences extending back to April 13, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Forte Biosciences stands at 19.79, as last reported on the 29th of November, with the highest price reaching 23.36 and the lowest price hitting 16.86 during the day.
If you're considering investing in Forte Stock, it is important to understand the factors that can impact its price. Forte Biosciences is risky given 3 months investment horizon. Forte Biosciences secures Sharpe Ratio (or Efficiency) of 0.14, which denotes the company had a 0.14% return per unit of risk over the last 3 months. We were able to interpolate data for thirty different technical indicators, which can help you to evaluate if expected returns of 2.36% are justified by taking the suggested risk. Use Forte Biosciences Mean Deviation of 5.94, coefficient of variation of 800.04, and Downside Deviation of 4.25 to evaluate company specific risk that cannot be diversified away.
At this time, Forte Biosciences' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 43.2 M in 2024, whereas Common Stock Total Equity is likely to drop 9,867 in 2024. . Price To Sales Ratio is likely to drop to 9.98 in 2024. Price Earnings Ratio is likely to drop to -0.87 in 2024. Forte Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 13th of April 2017 | 200 Day MA 12.4414 | 50 Day MA 6.5493 | Beta 1.455 |
Forte |
Sharpe Ratio = 0.1399
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | FBRX | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 16.85 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.36 actual daily | 47 53% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 11 89% of assets perform better |
Based on monthly moving average Forte Biosciences is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Forte Biosciences by adding it to a well-diversified portfolio.
Price Book 3.089 | Book Value 24.297 | Enterprise Value 12.6 M | Enterprise Value Ebitda 1.872 | Shares Float 882.3 K |
Related Headline
Tempest Therapeutics Headline on 18th of September 2024
Tempest Further Strengthens Leadership Team with Appointment... by finance.yahoo.com
Company welcomes additional late-stage expertise as it prepares for amezalpat pivotal studyBRISBANE, Calif., Sept. 18, 2024 -- Tempest Therapeutics, Inc. , a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced the appointment of Sheldon Mullins as Vice President, Regulatory Affairs. Mr. Mullins presence on the team builds upon the recent addition of Troy Wagner as Vice President
Forte Biosciences Valuation on September 18, 2024
It is possible to determine the worth of Forte Biosciences on a given historical date. On September 18, 2024 Forte was worth 7.0 at the beginning of the trading date compared to the closed value of 6.73. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Forte Biosciences stock. Still, in general, we apply an absolute valuation method to find Forte Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Forte Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Forte Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 7.45 | 7.50 | 6.86 | 7.09 | 15,868 | |
09/18/2024 | 7.00 | 7.18 | 6.60 | 6.73 | 9,794 |
| 7.06 | 7.35 | 6.91 | 7.01 | 3,654 |
| Backtest Forte Biosciences | | | Forte Biosciences History | | | Forte Biosciences Valuation | Previous | Next |
Forte Biosciences Trading Date Momentum on September 18, 2024
| On September 19 2024 Forte Biosciences was traded for 7.01 at the closing time. The top price for the day was 7.35 and the lowest listed price was 6.91 . The trading volume for the day was 3.7 K. The trading history from September 19, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 4.16% . The overall trading delta against the current closing price is 16.34% . |
Forte Biosciences Fundamentals Correlations and Trends
By evaluating Forte Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Forte Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Forte financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Forte Biosciences Stock history
Forte Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Forte is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Forte Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Forte Biosciences stock prices may prove useful in developing a viable investing in Forte Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.3 M | 862 K | |
| Net Loss | -16 M | -16.8 M |
Forte Biosciences Quarterly Net Working Capital |
|
Forte Biosciences Stock Technical Analysis
Forte Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Forte Biosciences Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Forte Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Forte Biosciences November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Forte Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Forte Biosciences shares will generate the highest return on investment. By undertsting and applying Forte Biosciences stock market strength indicators, traders can identify Forte Biosciences entry and exit signals to maximize returns
Forte Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Forte Biosciences' price direction in advance. Along with the technical and fundamental analysis of Forte Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Forte to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1053 | |||
| Jensen Alpha | 1.89 | |||
| Total Risk Alpha | (0.43) | |||
| Sortino Ratio | 0.4577 | |||
| Treynor Ratio | 1.37 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Forte Stock Analysis
When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.